Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
To subscribe to The Bloodline with LLS, click here.
How CAR T-cell Therapy Saved My Life: Chuck’s Story
On this episode, Alicia and Lizette speak with Chuck Colletti, a two-time survivor of Stage 4 follicular lymphoma. Chuck was diagnosed in early 2016 when he underwent 7 months of chemotherapy which put his cancer into temporary remission. Unfortunately, 7 months later, it returned in a more aggressive form. With options dwindling, he was accepted into a CAR T-cell therapy clinical trial. Listen in as he describes how this therapy impacted his life both emotionally and physically, the side effects he experienced and the hope he has in this therapy’s ability to save many more lives.
Support for this episode provided by Celgene; Kite, A Gilead Company; and Novartis Oncology.
Survivor Guilt: Common Yet Under-Discussed
Survivor’s guilt is not an unusual reaction among those who have experienced a traumatic event, especially those impacted by cancer. Join in as Shona sits down with Micheline Toussaint onsite at CancerCon 2019. CancerCon is an annual conference held every year by Stupid Cancer, an organization that provides support to young adult cancer survivors. Micheline is an Oncology Therapist at Inova Dwight and Martha Schar Cancer Institute in Fairfax, VA. On this episode, Micheline defines survivor guilt, how it differs from person to person and the impact it has on an individual and their loved ones. She also shares coping mechanisms that she uses to treat patients as well as helpful resources available to those who may be experiencing survivor guilt.
CAR T-cell Explained: Recovering from CAR T-cell Therapy
On this episode, Alicia and Lizette speak with Dr. Rayne H. Rouce. Dr. Rouce is a pediatric hematologist and oncologist at Texas Children’s Cancer Center where she is a member of the Leukemia and Bone Marrow Transplant programs. She works as part of The Center for Cell and Gene Therapy at Baylor College of Medicine, focused on translating targeted T-cell therapies, and has been involved in every aspect of CAR T-cell development for clinical use. On this episode, Dr. Rouce explains what types of cancers chimeric antigen receptor T-cell therapy, known as CAR T-cell therapy, currently treats, when it may be considered for treatment and why the recovery process may be different for each person. She addresses quality-of-life issues and recommends great questions about CAR T-cell therapy that a patient or caregiver should consider asking their healthcare team. Dr. Rouce shares her excitement for how she sees this therapy improving in the future and continues to work towards discovering how it can be a hopeful option for more and more patients.
Support for this episode provided by Celgene; Kite, A Gilead Company; and Novartis.
Support for The Bloodline with LLS provided by Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene, Jazz Pharmaceuticals; Kite, A Gilead Company; Novartis; Pharmacyclics, an AbbVie company and Janssen Biotech; Seattle Genetics and Takeda Oncology.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.
To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.